Goldman Sachs’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,000
Closed -$2.26M 6619
2025
Q4
$2.26M Buy
+100,000
New +$2.18M ﹤0.01% 4470
2020
Q3
Sell
-117,900
Closed -$2.53M 5362
2020
Q2
$2.53M Buy
117,900
+67,900
+136% +$1.5M ﹤0.01% 3288
2020
Q1
$1.12M Buy
+50,000
New +$1.37M ﹤0.01% 3673

Other funds holding ELAN

Goldman Sachs's ELAN Position: Q1 2026 in Review

Goldman Sachs reduced its Elanco Animal Health (ELAN) stake by 3.6% in Q1 2026, selling an estimated $1.31M and leaving 1,434,135 shares worth $34.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

Goldman Sachs first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $345M in Q2 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Goldman Sachs held 1,434,135 shares of Elanco Animal Health worth $34.3M as of Q1 2026.
  • Goldman Sachs sold 53,574 Elanco Animal Health shares in Q1 2026, an estimated $1.31M.
  • Elanco Animal Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1909 holding.
  • Goldman Sachs first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
  • Goldman Sachs's Elanco Animal Health position peaked at $345M in Q2 2021.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.